Company / Inventory
Viatris Inventory History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$4.0B
FY2025
5-year range
$3.5B / $4.0B
FY2021-FY2025
Trend
+3.8%
vs FY2024
Sector context
#7 of 105
Health Care
What the data says
Among 105 Health Care companies, Viatris is in the top 7% for inventory. Improved from $3.5B to $4.0B over the past 2 years.
Based on SEC 10-K filings.
$4.0B in FY2025 with a 5-year CAGR of -6.1%. Top quartile in the Health Care sector.
Improved from $3.5B to $4.0B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- -6.1%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 105This company $4.0B Sector average $885.3M
▼
+351.7% above sector average
Key checks
Key Insights
- 5-year CAGR of -6.1%, indicating a declining trend.
- In FY2025, inventory increased 3.8% year-over-year.
- Ranks #7 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.0B | +3.8% |
| FY2024 | $3.9B | +11.1% |
| FY2023 | $3.5B | -1.4% |
| FY2022 | $3.5B | -11.5% |
| FY2021 | $4.0B | -27.3% |
| FY2020 | $5.5B | +104.9% |
| FY2019 | $2.7B | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026